Shuoming Luo1, Jian Lin1, Zhiguo Xie1, Yufei Xiang1, Peilin Zheng1, Gan Huang1, Xia Li1, Yu Liao1, William A Hagopian1, Cong-Yi Wang1, Zhiguang Zhou1. 1. Department of Metabolism and Endocrinology (S.L., J.L., Z.X., Y.X., P.Z., G.H., X.L., Y.L., C.-Y.W., Z.Z.), Second Xiangya Hospital and Diabetes Center, Institute of Metabolism and Endocrinology, Central South University, and Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan 410011, China; Pacific Northwest Diabetes Research Institute and University of Washington (W.A.H.), Seattle, Washington 98122; and The Center for Biomedical Research (C.-Y.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
Abstract
CONTEXT: The discrepancies in terms of human leukocyte antigen (HLA)-DRB1-DQA1-DQB1 conferred risks between latent autoimmune diabetes in adults (LADA) and type 1 diabetes (T1D) patients remained almost completely unknown. The goal of the current study is to determine and compare HLA-conferred risks between LADA and T1D. DESIGN: A case-control study was conducted in a representative Chinese data set containing 520 T1D patients, 562 LADA patients, and 1065 controls. The frequencies and odds ratios for HLA susceptible haplotypes and genotypes and for arginine at residue 52 in the DQ-α chain or aspartic acid at residue 57 in the DQ-β chain were analyzed. RESULTS: DRB1*0405-DQA1*03-DQB1*0401 and DRB1*0901-DQA1*03-DQB1*0303 are the major LADA susceptible haplotypes, which also confer comparable risks for T1D (odds ratio 2.02 vs 2.20 and 1.61 vs 2.30, respectively). The strongly associated T1D haplotype DRB1*0301-DQA1*05-DQB1*0201 is also associated with LADA but confers only half of the T1D risk (odds ratio 2.65 vs 4.84). Interestingly, the most susceptible T1D haplotypes, DRB1*0901-DQA1*05-DQB1*0201, DRB1*0301-DQA1*03-DQB1*0201, and DRB1*0301-DQA1*03-DQB1*0303, are not associated with LADA. Genotypes for DR3/DR3, DR3/DR9, and DR9/DR9 are highly associated with T1D susceptibility, whereas only DR9/DR9 confers risk for LADA. DR3/DR3 is the high-risk genotype in Chinese T1D patients, which manifests similar risk as the DR3/DR4 genotype in Caucasians but with a lower frequency. DR9/DR9 is the high risk LADA genotype in Chinese. Alleles with DQ-α arginine at residue 52-positive, DQ-β aspartic acid at residue 57-negative, and their combination formed in cis or trans confer susceptibility to T1D but not to LADA. CONCLUSION: Our results suggest that LADA risk conferred by HLA-DRB1-DQA1-DQB1 loci in Chinese differs significantly from that of T1D risk. This information would be useful for classifying Asian LADA patients, which should provides novel insight into the understanding of its pathoetiology as well.
CONTEXT: The discrepancies in terms of humanleukocyte antigen (HLA)-DRB1-DQA1-DQB1 conferred risks between latent autoimmune diabetes in adults (LADA) and type 1 diabetes (T1D) patients remained almost completely unknown. The goal of the current study is to determine and compare HLA-conferred risks between LADA and T1D. DESIGN: A case-control study was conducted in a representative Chinese data set containing 520 T1D patients, 562 LADA patients, and 1065 controls. The frequencies and odds ratios for HLA susceptible haplotypes and genotypes and for arginine at residue 52 in the DQ-α chain or aspartic acid at residue 57 in the DQ-β chain were analyzed. RESULTS:DRB1*0405-DQA1*03-DQB1*0401 and DRB1*0901-DQA1*03-DQB1*0303 are the major LADA susceptible haplotypes, which also confer comparable risks for T1D (odds ratio 2.02 vs 2.20 and 1.61 vs 2.30, respectively). The strongly associated T1D haplotype DRB1*0301-DQA1*05-DQB1*0201 is also associated with LADA but confers only half of the T1D risk (odds ratio 2.65 vs 4.84). Interestingly, the most susceptible T1D haplotypes, DRB1*0901-DQA1*05-DQB1*0201, DRB1*0301-DQA1*03-DQB1*0201, and DRB1*0301-DQA1*03-DQB1*0303, are not associated with LADA. Genotypes for DR3/DR3, DR3/DR9, and DR9/DR9 are highly associated with T1D susceptibility, whereas only DR9/DR9 confers risk for LADA. DR3/DR3 is the high-risk genotype in Chinese T1D patients, which manifests similar risk as the DR3/DR4 genotype in Caucasians but with a lower frequency. DR9/DR9 is the high risk LADA genotype in Chinese. Alleles with DQ-α arginine at residue 52-positive, DQ-β aspartic acid at residue 57-negative, and their combination formed in cis or trans confer susceptibility to T1D but not to LADA. CONCLUSION: Our results suggest that LADA risk conferred by HLA-DRB1-DQA1-DQB1 loci in Chinese differs significantly from that of T1D risk. This information would be useful for classifying Asian LADA patients, which should provides novel insight into the understanding of its pathoetiology as well.
Authors: Rajashree Mishra; Mikael Åkerlund; Diana L Cousminer; Emma Ahlqvist; Jonathan P Bradfield; Alessandra Chesi; Kenyaita M Hodge; Vanessa C Guy; David J Brillon; Richard E Pratley; Michael R Rickels; Adrian Vella; Fernando Ovalle; Ronald I Harris; Olle Melander; Stephen Varvel; Hakon Hakonarson; Phillippe Froguel; John T Lonsdale; Didac Mauricio; Nanette C Schloot; Kamlesh Khunti; Carla J Greenbaum; Knud B Yderstræde; Tiinamaija Tuomi; Benjamin F Voight; Stanley Schwartz; Bernhard O Boehm; Leif Groop; Richard David Leslie; Struan F A Grant Journal: Diabetes Care Date: 2019-12-16 Impact factor: 19.112
Authors: Juan Huang; James Alexander Pearson; F Susan Wong; Li Wen; Zhiguang Zhou Journal: Diabetes Metab Res Rev Date: 2021-06-22 Impact factor: 4.876
Authors: Diana L Cousminer; Emma Ahlqvist; Rajashree Mishra; Mette K Andersen; Alessandra Chesi; Mohammad I Hawa; Asa Davis; Kenyaita M Hodge; Jonathan P Bradfield; Kaixin Zhou; Vanessa C Guy; Mikael Åkerlund; Mette Wod; Lars G Fritsche; Henrik Vestergaard; James Snyder; Kurt Højlund; Allan Linneberg; Annemari Käräjämäki; Ivan Brandslund; Cecilia E Kim; Daniel Witte; Elin Pettersen Sørgjerd; David J Brillon; Oluf Pedersen; Henning Beck-Nielsen; Niels Grarup; Richard E Pratley; Michael R Rickels; Adrian Vella; Fernando Ovalle; Olle Melander; Ronald I Harris; Stephen Varvel; Valdemar E R Grill; Hakon Hakonarson; Philippe Froguel; John T Lonsdale; Didac Mauricio; Nanette C Schloot; Kamlesh Khunti; Carla J Greenbaum; Bjørn Olav Åsvold; Knud B Yderstræde; Ewan R Pearson; Stanley Schwartz; Benjamin F Voight; Torben Hansen; Tiinamaija Tuomi; Bernhard O Boehm; Leif Groop; R David Leslie; Struan F A Grant Journal: Diabetes Care Date: 2018-09-25 Impact factor: 19.112